just went back to look at what AHZ actually said about preliminary results of Phase 1 trials...
looking at current pricing it appears to me that the market is back to factoring in only CardioCel stuff and is discounting the possibility of any sparkling results of vaccine trials. Completion of trial results is now well past its use-by date so that says to me some drama has been encountered along the way?
(from 13 February 2014)
buyers v sellers, page-52
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.00 |
Change
-0.150(1.48%) |
Mkt cap ! $211.3M | |||
| Open | High | Low | Value | Volume |
| $10.26 | $10.35 | $9.80 | $295.8K | 29.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22 | $9.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 2758 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |